enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
Holders of 5% or more of NVNO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of enVVeno Medical Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 13G/A | 9.99%2.05M shares | – | Feb 17, 20261 filing | Feb 17, 2026 | SEC |
| Satterfield Thomas A Jr | 13G | 9.00%1.82M shares | New | Nov 19, 20251 filing | Nov 19, 2025 | SEC |
| Kingdon Capital Management, L.L.C. | 13G | 7.10%1.36M shares | New | Sep 9, 20251 filing | Sep 9, 2025 | SEC |
| Braeden Lichti | 13D | 5.05%33.2K shares | 0.00 ppfrom 5.05% | Feb 10, 20262 filings | Feb 20, 2026 | SEC |
| Northstrive Fund II LP | 13D | 5.05%33.2K shares | 0.00 ppfrom 5.05% | Feb 10, 20262 filings | Feb 20, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
9 Schedule 13D and 13G filings on enVVeno Medical Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 20, 20269:43 AM ET | Braeden Lichtiand 1 other | 13D | 5.05%33.2K shares | 0.00 ppfrom 5.05% | Feb 20, 2026 | SEC |
| Feb 20, 20269:43 AM ET | Northstrive Fund II LPand 1 other | 13D | 5.05%33.2K shares | 0.00 ppfrom 5.05% | Feb 20, 2026 | SEC |
| Feb 17, 20264:00 PM ET | Perceptive Advisors LLCand 2 others | 13G/A | 9.99%2.05M shares | – | Dec 31, 2025 | SEC |
| Feb 10, 20264:29 PM ET | Northstrive Fund II LPand 1 other | 13G | 5.05%33.2K shares | New | Feb 10, 2026 | SEC |
| Feb 10, 20264:28 PM ET | Braeden Lichtiand 1 other | 13G | 5.05%33.2K shares | New | Feb 10, 2026 | SEC |
| Nov 19, 20254:08 PM ET | Satterfield Thomas A Jr | 13G | 9.00%1.82M shares | New | Nov 14, 2025 | SEC |
| Nov 14, 20254:40 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 3.46%688.9K shares | −3.60 ppfrom 7.06%Below 5% | Sep 30, 2025 | SEC |
| Sep 9, 202512:58 PM ET | Kingdon Capital Management, L.L.C.and 3 others | 13G | 7.10%1.36M shares | New | Sep 2, 2025 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 7.06%1.29M shares | – | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell enVVeno Medical Corp shares.
No Form 144 notices for enVVeno Medical Corp are on file.